The C-peptide seems to accomplish these effects without reducing hyperglycemia. It has no insulinlike action and so acts without changing any of the usual metabolic parameters that are deranged in diabetes. In addition to hyperglycemia and hyperlipidemia, these include elevation of sorbitol in tissues, a consequence of hyperglycemia that can lead to cataracts and degenerative changes.
[HN6] C-peptide administration also does not prevent the increased nonenzymatic glycation of proteins, which has also been implicated in retinal, nerve, kidney, and general vascular degenerative processes in diabetes. [In support of these results, in diabetic humans (2) C-peptide shows beneficial effects on microcirculation, vascular permeability, and sodium-potassium ATPase, but in contrast it also improves glucose utilization and glycemia.]
What is even more remarkable about this action of C-peptide is that it seems not to follow the usual rules of ligand and receptor chemistry. Its action does not require the normal chirality of the peptide, a property that may be attributable to the glycine-rich central portion. A C-peptide made up of Damino acids is equally active, as is a peptide synthesized with amino acids in the reversed order, carboxyl terminal to amino terminal. The central glycine-rich region is largely achiral, is extremely flexible, and is well conserved in most, but not all, of the mammalian C-peptides. Both the rat and the human peptides are active in their systems, whereas the porcine (and possibly also bovine) peptides, which have deletions in the central region, appear to be inactive or less active. It should be noted that Prev | complications in type II diabetes, in which insulin and C-peptide secretion are significantly retained, do not differ from those of insulin-dependent diabetes, characterized by absent C-peptide (endogenous and exogenous).
How can these new observations be explained? The authors suggest that C-peptides may function like some antibiotic peptides, which assemble into bacterial membranes to form pores or channels that disrupt normal ion flow and membrane integrity and thereby inhibit cellular function. The C-peptides, however, differ significantly in their structure from these antibiotic peptides. It seems unlikely that they could form membrane channels, especially since the C-peptides show no tendency to selfassociate and are rather polar (negatively charged).
The C-peptide serves several functions as part of the precursor of insulin. Its main function is to bring the A and B chains together into a single molecule so that the process of folding and interchain disulfide bond formation necessary for generating mature insulin can be accomplished as an intramolecular event. However, simply linking the B and A chains together in series, without a Cpeptide spacer, also will accomplish this goal and produce a normally folded miniproinsulin. Although such molecules can be transported and stored, they are biologically inactive because the carboxylterminal part of the B chain, by virtue of its covalent linkage to the amino-terminal glycine of the A chain, is not free to move to assume the appropriate conformation necessary for productive interaction with insulin receptors. The C-peptide overcomes this problem by providing a spacer sequence that can be removed by proteolytic processing. Evolutionary studies suggest that a length of approximately 30 amino acids is ideal for the dual role of promoting the folding of proinsulin and then permitting its efficient processing. Modeling studies on proinsulin indicate that a C-peptide of this length provides sufficient flexibility in the dibasic cleavage sites at either end of the connecting segment for their appropriate interaction with the prohormone convertases, PC2 (SPC2) and PC1/PC3 (SPC3), which carry out this conversion in the maturing secretory vesicles (see the figure). Once this goal is accomplished, the excised C-peptide is stored with insulin in the mature granules and secreted along with it into the bloodstream (3).
Human proinsulin with its C-peptide.
Insulin A chain (purple), B chain (yellow), and Cpeptide (blue). The CA and BC junctions, the dibasic processing sites (R31-R32 and K64-R65), are shown suitably poised for interaction with the prohormone convertases (3). Pro48 (P48) corresponds to Pro16 [in figure 6 of (1)]. [Model by G. Lipkind, with Biosyn Technologies Software] Is it indeed possible, then, that in the course of evolution these "shavings from the carpenter's bench," derived from the formation of the indispensable insulin molecule, have taken on a life of their own, one which might independently complement the role of insulin by affecting specific cellular processes? The C-peptide might also exert effects that are not within the repertoire of insulin itself. Although at present there is no known paradigm for a molecule to function in such a manner, it is conceivable that C-peptide can interact either with membranes or with some proteins within membranes in a transient manner to modify their functional properties. Receptors for the C-peptide have not yet been isolated, and its relatively slow metabolism suggests that it diffuses freely into the extracellular space, but is not associated with cell membranes (4). Alternatively, the glycine-rich central domain might function as a scavenger, binding noxious agents, ions, or metabolic by-products. An interesting analogy might be the recent discovery that certain polyamides can hydrogen bond to specific DNA sequences to modify gene expression in cells (5) . These tantalizing possibilities certainly deserve further study, especially with the objective of improving the therapy of diabetes by a judicious (and more physiological?) combination of C-peptide and insulin-possibly closer to "nature's own way."
HyperNotes Related Resources on the World Wide Web
The Dictionary of Cell Biology (London, Academic Press, 1995) defines some of the terms used in this article.
Online Mendelian Inheritance in Man (OMIM) includes basic information on insulin and diabetes http://www.sciencemag.org/content/277/5325/531.long The ExPASy World Wide Web (WWW) molecular biology server of the Geneva University Hospital and the University of Geneva is dedicated to the analysis of protein and nucleic acid sequences. It provides access to SWISS-PROT, the annotated protein sequence database; PROSITE, the dictionary of protein sites and patterns; SWISS-3DIMAGE, a database of three-dimensional images of proteins and other biological macromolecules; and other databases. 6. Hyperlipidemia is one of the many topics covered by the American Heart Association.
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